Home Newsfeeds GE Gas Power Awarded $4.2M In Funding From ARPA-E To Develop Decarbonization Technologies

GE Gas Power Awarded $4.2M In Funding From ARPA-E To Develop Decarbonization Technologies

https://www.ge.com/news/press-releases/ge-gas-power-awarded-42-million-in-funding-from-arpa-e-to-develop-breakthrough

byBenzinga Newsdesk

July 28, 2022

1 minute read

https://www.ge.com/news/press-releases/ge-gas-power-awarded-42-million-in-funding-from-arpa-e-to-develop-breakthrough

Abercrombie & Fitch Boosts Q4 Outlook On Solid Holiday Sales

By Shivani Kumaresan

January 9, 3:31 PM

Abercrombie & Fitch Co (NYSE:ANF) has raised its fourth-quarter FY22 sales outlook from a 2% – 4% decline to an…

ANF

Amgen Responds To FTC Action Re: Proposed Acquisition Of Horizon Therapeutics; Says Disappointed By The FTC’s Decision And Remains Committed To Completing This Acquisition

By Happy Mohamed

May 16, 11:32 AM

Amgen (NASDAQ:AMGN) today issued the following statement in response to the U.S. Federal Trade Commission's (FTC) complaint seeking to block the company's proposed acquisition of Horizon Therapeutics

AMGN

A Shot of Success: GSK’s Arexvy Wins FDA Approval, Pioneering RSV Prevention for Older Adults in Multi-Billion Dollar Market

By Vandana Singh

May 3, 3:38 PM

The FDA has approved GSK Plc's (NYSE: GSK) Arexvy (respiratory syncytial virus vaccine for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals

GSK

Cenntro Electric’s LS400 Model Completes EPA Tests

By Shivani Kumaresan

October 7, 12:17 PM

Cenntro Electric Group Ltd’s (NASDAQ:CENN) All-Electric Class 4 Logistar 400 (LS400) model has completed its EPA tests, marking a…

CENN

GE Gas Power Awarded $4.2M In Funding From ARPA-E To Develop Decarbonization Technologies

Related Posts

Abercrombie & Fitch Boosts Q4 Outlook On Solid Holiday Sales

Amgen Responds To FTC Action Re: Proposed Acquisition Of Horizon Therapeutics; Says Disappointed By The FTC’s Decision And Remains Committed To Completing This Acquisition

A Shot of Success: GSK’s Arexvy Wins FDA Approval, Pioneering RSV Prevention for Older Adults in Multi-Billion Dollar Market

Cenntro Electric’s LS400 Model Completes EPA Tests